Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)

Hyundai Bioscience Revenue

Hyundai Bioscience had revenue of 458.72M KRW in the quarter ending September 30, 2024, a decrease of -76.63%. This brings the company's revenue in the last twelve months to 15.82B, up 57.22% year-over-year. In the year 2023, Hyundai Bioscience had annual revenue of 9.48B with 20.76% growth.

• Revenue (ttm): 15.82B
• Revenue Growth: +57.22%
• P/S Ratio: 36.87
• Revenue / Employee: 292.93M
• Employees: 54
• Market Cap: 583.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.48B	1.63B	20.76%
Dec 31, 2022	7.85B	-1.39B	-15.04%
Dec 31, 2021	9.24B	-3.27B	-26.14%
Dec 31, 2020	12.51B	-17.57B	-58.41%
Dec 31, 2019	30.09B	-1.15B	-3.68%